Cell and Gene Therapy, Clinical Trials, Industry, Research and Development
October 7, 2022
Via: Biopharma DiveAllogene Therapeutics has begun the first pivotal test of an “off-the-shelf” cell therapy for cancer. The biotechnology company, which has been at the forefront of a push in recent years to develop such treatments, known as allogeneic therapies and derived […]
September 22, 2022
Via: Biopharma DiveFrench drugmaker Servier has terminated a partnership with Allogene, ending a deal whose origins began well before the high-profile developer of “off-the-shelf” cancer cell therapies was formed four years ago. A regulatory filing on Wednesday by Allogene revealed Servier’s decision […]
September 21, 2023
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 1, 2023
August 30, 2023
September 19, 2023
Copyright © 2023. All rights reserved
